Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-05

FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for HALOPERIDOL DECANOATE from BluePoint Laboratories. This approval supports the continued authorization/availability o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)